Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

A gene called Gk5 controls lipid production in the skin and affects hair growth.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Topical IKKα inhibitors may help prevent CCS tumours.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

MCP@G improves diabetic wound healing by reducing stress and promoting tissue repair.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

GPIGS peptide increases thick hair growth in balding Japanese men.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Overexpression of LRIG3 in skin causes hair loss.

JAK inhibitors show promise for treating various skin diseases.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

Wnt/β-catenin activators can help regrow hair lost due to diabetes.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Blocking mTORC1 reduces skin tumor growth in mice.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.